Indeed, although differences did not reach statistical significance, the percentage of diffuse CD20-positive B cells expressing IRAK1 was higher in thymuses from untreated MG patients compared to control and corticosteroid-treated MG patients' thymuses (Figure 3B). The gene discussed is IRAK1; the disease is myasthenia gravis.